People · Operator
Named in public records as an officer, director or promoter · active 2009–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Olive Medical Corp | — | Biotechnology | Pre-Seed | $2.6M | $55.2M | 2010 |
| MediProPharma, Inc. | — | Biotechnology | Pre-Seed | $645K | $35.6M | 2009 |
S. George Simon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside S. George Simon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Theodore H. Stanley | 1 | 2 |
| J. Michael Brown | 1 | 2 |
| Curtis Wichern | 1 | 1 |
| Laurant George Blanquart | 1 | 1 |
| Jeremiah Henley | 1 | 1 |
| Dann George Hughes | 1 | 1 |
| Joshua Talbert | 1 | 1 |
| Donald Wichern | 1 | 1 |
| Milton Drake | 1 | 1 |
| Thomas N. Parks | 1 | 1 |
| Irina Shcherbakova | 1 | 1 |
| Shane A. Johnson | 1 | 1 |
| Thomas N. Parker | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.